Original Article

You have full text access to this OnlineOpen article

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality†‡

  1. Margaret E. Wright PhD1,§,¶,*,
  2. Shih-Chen Chang PhD1,§,
  3. Arthur Schatzkin MD, DrPH1,
  4. Demetrius Albanes MD1,
  5. Victor Kipnis PhD2,
  6. Traci Mouw MPH1,
  7. Paul Hurwitz MPH3,
  8. Albert Hollenbeck PhD4,
  9. Michael F. Leitzmann MD, DrPH1

Article first published online: 8 JAN 2007

DOI: 10.1002/cncr.22443

Issue

Cancer

Cancer

Volume 109, Issue 4, pages 675–684, 15 February 2007

Additional Information

How to Cite

Wright, M. E., Chang, S.-C., Schatzkin, A., Albanes, D., Kipnis, V., Mouw, T., Hurwitz, P., Hollenbeck, A. and Leitzmann, M. F. (2007), Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer, 109: 675–684. doi: 10.1002/cncr.22443

Author Information

  1. 1

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland

  2. 2

    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland

  3. 3

    Westat, Inc., Rockville, Maryland

  4. 4

    AARP, Washington, DC

  1. §

    The first 2 authors contributed equally to this work.

  2. Fax: (312) 996-7586.

*Department of Pathology MC847, University of Illinois at Chicago, 840 South Wood Street, Room 130 CSN, Chicago, IL 60612

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

  2. ‡

    Cancer incidence data from the Atlanta metropolitan area were collected by the Georgia Center for Cancer Statistics, Department of Epidemiology, Rollins School of Public Health, Emory University; from California by the California Department of Health Services, Cancer Surveillance Section; from the Detroit metropolitan area by the Michigan Cancer Surveillance Program, Community Health Administration, State of Michigan; from Florida by the Florida Cancer Data System under contract to the Department of Health (DOH), and the views expressed herein are solely those of the authors and do not necessarily reflect those of the contractor or DOH; from Louisiana by the Louisiana Tumor Registry, Louisiana State University Medical Center in New Orleans; from New Jersey by the New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey State Department of Health and Senior Services; from North Carolina by the North Carolina Central Cancer Registry; from Pennsylvania by the Division of Health Statistics and Research, Pennsylvania Department of Health, Harrisburg, Pennsylvania, and the Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.

Publication History

  1. Issue published online: 2 FEB 2007
  2. Article first published online: 8 JAN 2007
  3. Manuscript Accepted: 11 NOV 2006
  4. Manuscript Revised: 10 NOV 2006
  5. Manuscript Received: 19 SEP 2006

Funded by

  • Intramural Research Program of the National Institutes of Health
  • National Cancer Institute

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (150K)

REFERENCES

  • 1
    Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002; 288: 1723–1727.
  • 2
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289: 76–79.
  • 3
    Macinnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006; 17: 989–1003.
  • 4
    Giovannucci E, Rimm EB, Liu Y, et al. Body mass index and risk of prostate cancer in U.S. health professionals. JNatl Cancer Inst. 2003; 95: 1240–1244.
  • 5
    Cerhan JR, Torner JC, Lynch CF, et al. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control. 1997; 8: 229–238.
  • 6
    MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1417–1421.
  • 7
    Putnam SD, Cerhan JR, Parker AS, et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol. 2000; 10: 361–369.
  • 8
    Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst. 1997; 89: 385–389.
  • 9
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625–1638.
  • 10
    Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001; 10: 345–353.
  • 11
    Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol. 1984; 120: 244–250.
  • 12
    Freedland SJ, Isaacs WB, Mangold LA, et al. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years. Clin Cancer Res. 2005; 11: 2883–2888.
  • 13
    Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997; 6: 557–563.
  • 14
    Jonsson F, Wolk A, Pedersen NL, et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer. 2003; 106: 594–599.
    Direct Link:
  • 15
    Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst. 1985; 74: 319–323.
  • 16
    Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol. 2000; 151: 541–549.
  • 17
    Strom SS, Wang X, Pettaway CA, et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res. 2005; 11(19 Pt 1): 6889–6894.
  • 18
    Freedland SJ. Obesity and prostate cancer: a growing problem. Clin Cancer Res. 2005; 11(19 Pt 1): 6763–6766.
  • 19
    Freedland SJ, Giovannucci E, Platz EA. Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control. 2006; 17: 5–9.
  • 20
    Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001; 154: 1119–1125.
  • 21
    FlemingID, CooperJS, HensenDE, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998.
  • 22
    Chyou PH, Nomura AM, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer. 1994; 57: 313–317.
    Direct Link:
  • 23
    Clarke G, Whittemore AS. Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Cancer Epidemiol Biomarkers Prev. 2000; 9: 875–881.
  • 24
    Habel LA, Van Den Eeden SK, Friedman GD. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000; 43: 136–143.
    Direct Link:
  • 25
    Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control. 1994; 5: 66–72.
  • 26
    Hubbard JS, Rohrmann S, Landis PK, et al. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging. Urology. 2004; 63: 253–258.
  • 27
    Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer. 2006; 94: 740–742.
  • 28
    Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology. 1994; 5: 276–282.
  • 29
    Lee IM, Sesso HD, Paffenbarger RSJr. A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control. 2001; 12: 187–193.
  • 30
    Lukanova A, Bjor O, Kaaks R, et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006; 118: 458–466.
    Direct Link:
  • 31
    Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989; 64: 598–604.
    Direct Link:
  • 32
    Nilsen TI, Vatten LJ. Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men. Cancer Causes Control. 1999; 10: 269–275.
  • 33
    Severson RK, Grove JS, Nomura AM, Stemmermann GN. Body mass and prostatic cancer: a prospective study. BMJ. 1988; 297: 713–715.
  • 34
    Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol. 1989; 129: 511–517.
  • 35
    Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001; 12: 13–21.
  • 36
    Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer. 2003; 89: 1237–1242.
  • 37
    Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994; 30A: 344–350.
  • 38
    Thune I, Lund E. Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control. 1994; 5: 549–556.
  • 39
    Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer. 1997; 73: 634–638.
    Direct Link:
  • 40
    Pollard M, Luckert PH, Schmidt MA. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate. 1982; 3: 563–568.
    Direct Link:
  • 41
    Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt—a major factor in the genesis of morbid obesity. Med Hypotheses. 1999; 52: 49–51.
  • 42
    Platz EA, Leitzmann MF, Rifai N, et al. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1262–1269.
  • 43
    Gennigens C, Menetrier-Caux C, Droz JP. Insulin-like growth factor (IGF) family and prostate cancer. Crit Rev Oncol Hematol. 2006; 58: 124–145.
  • 44
    Ribeiro R, Lopes C, Medeiros R. The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis. 2006; 9: 12–24.
  • 45
    Frankenberry KA, Somasundar P, McFadden DW, Vona-Davis LC. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 2004; 188: 560–565.
  • 46
    Willett WC. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press, 1998.
  • 47
    Stevens J, Keil JE, Waid LR, Gazes PC. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol. 1990; 132: 1156–1163.
  • 48
    Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res. 2002; 10( suppl 1): 14S–21S.
View Full Article (HTML) Get PDF (150K)